Loxo Oncology Stock Total Debt
Loxo Oncology fundamentals help investors to digest information that contributes to Loxo Oncology's financial success or failures. It also enables traders to predict the movement of Loxo Stock. The fundamental analysis module provides a way to measure Loxo Oncology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Loxo Oncology stock.
Loxo |
Loxo Oncology Company Total Debt Analysis
Loxo Oncology's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Loxo Oncology has a Total Debt of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The total debt for all United States stocks is 100.0% higher than that of the company.
Loxo Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Loxo Oncology's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Loxo Oncology could also be used in its relative valuation, which is a method of valuing Loxo Oncology by comparing valuation metrics of similar companies.Loxo Oncology is currently under evaluation in total debt category among related companies.
Loxo Fundamentals
| Return On Equity | -0.63 | |||
| Return On Asset | -0.0059 | |||
| Profit Margin | (43.49) % | |||
| Operating Margin | (50.33) % | |||
| Current Valuation | 6.56 B | |||
| Shares Outstanding | 30.75 M | |||
| Shares Owned By Insiders | 3.70 % | |||
| Shares Owned By Institutions | 92.93 % | |||
| Number Of Shares Shorted | 1.03 M | |||
| Price To Earning | (20.33) X | |||
| Price To Book | 18.92 X | |||
| Price To Sales | 49.84 X | |||
| Revenue | 144.8 M | |||
| Gross Profit | (118.74 M) | |||
| EBITDA | (147.98 M) | |||
| Net Income | (62.98 M) | |||
| Cash And Equivalents | 622 M | |||
| Cash Per Share | 3.71 X | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 3.62 X | |||
| Book Value Per Share | 12.50 X | |||
| Cash Flow From Operations | 234.3 M | |||
| Short Ratio | 0.50 X | |||
| Earnings Per Share | (2.09) X | |||
| Price To Earnings To Growth | (2.75) X | |||
| Number Of Employees | 59 | |||
| Beta | 2.97 | |||
| Market Capitalization | 7.22 B | |||
| Total Asset | 157.46 M | |||
| Retained Earnings | (82.93 M) | |||
| Working Capital | 153.79 M | |||
| Current Asset | 156.64 M | |||
| Current Liabilities | 2.85 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Loxo Oncology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Loxo Oncology's short interest history, or implied volatility extrapolated from Loxo Oncology options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Loxo Stock
If you are still planning to invest in Loxo Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Loxo Oncology's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |